Publicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (15)

2020

  1. Predictive biomarkers of response to immune checkpoint inhibitors

    Farmacia Hospitalaria, Vol. 44, Núm. 4, pp. 141-148

2017

  1. Evaluation of standardized triple intrathecal therapy toxicity in oncohematological adult patients

    Farmacia Hospitalaria, Vol. 41, Núm. 5, pp. 611-617

  2. Potential drug-drug interactions in hospitalised haematological patients

    Journal of Oncology Pharmacy Practice, Vol. 23, Núm. 6, pp. 443-453

2015

  1. Potential drug–drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors

    International Journal of Clinical Pharmacy, Vol. 37, Núm. 6, pp. 1021-1027

2014

  1. Pharmacoepidemiological study of drug–drug interactions in onco-hematological pediatric patients

    International Journal of Clinical Pharmacy, Vol. 36, Núm. 6, pp. 1160-1169

2007

  1. Errores de prescripción en quimioterapia

    Farmacia Hospitalaria, Vol. 31, Núm. 3, pp. 161-164

2006

  1. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36%® and Dianeal PD1 3.86%®)

    Journal of Clinical Pharmacy and Therapeutics, Vol. 31, Núm. 6, pp. 641-643

1990

  1. Toxic epidermal necrolysis (Lyell syndrome), probably due by diclofenac

    Farmacia Hospitalaria, Vol. 14, Núm. 5, pp. 249-250

1989

  1. Anticonvulsant monitoring evaluation. A three and a half year study period

    Pharmaklinik, Vol. 3, Núm. 4, pp. 9-16

  2. SOMATOSTATINA Y SU ANALOGO SMS 201-995

    Revista de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 13, Núm. 3, pp. 213-221